Potential of Cocoa Pod Husk Pectin-Based Modified Release Capsules as a Carrier for Chronodelivery of Hydrocortisone in Sprague-Dawley Rats
Journal of Drug Delivery · 08.10.2018 · 2018 · 1-8
DOI: 10.1155/2018/9825363 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drug Delivery, erschienen am 08.10.2018. Verfasst von Ofosua Adi-Dako und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Tec…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universities Science, Humanities and Engineering Partnerships in Africa, University of Ghana.
Abstract (Originalsprache)
The potential of cocoa pod husk (CPH) pectin-based modified release (MR) capsules as a carrier for chronodelivery of hydrocortisone in Sprague-Dawley rats was assessed. Extemporaneously formulated CPH pectin-based hydrocortisone (10 mg) capsules crosslinked with calcium chloride (Formulation A) or zinc (Formulation B) and a commercial immediate release hydrocortisone formulation were administered orally to Sprague-Dawley rats and the pharmacokinetic parameters were evaluated using noncompartmental analysis. Formulation A had a 2 h lag phase followed by an increase in serum drug concentration in the treated rats. Peak concentrations ( C m a x ) of 21.799 ± 1.993 ng/ml and 20.844 ± 2.661 ng/ml were achieved after 6 ± 0.23 h and 6 ± 0.35 h ( T m a x ), respectively, for capsules A and B. The immediate release formulation had a peak concentration of 15.322 ± 0.313 ng/ml within 1 ± 0.2 h. The relative bioavailability of the CPH pectin-based capsules A and B was 213% and 274%, respectively. Formulations A and B had half-lives more than three times that of the immediate release formulation. The MR capsules exhibited a higher exposure, greater bioavailability, and versatility in release of cortisol than the commercial immediate release formulation. Additionally, the MR capsules exhibited an extended drug release with overnight cortisol rise and early morning cortisol peak and hold promise in the management of adrenal insufficiency.
Autor:innen und Institutionen
- Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana.
- Department of Pharmaceutics and Microbiology, University of Ghana School of Pharmacy, Accra, Ghana.
- Department of Pharmacology and Toxicology, University of Ghana School of Pharmacy, Accra, Ghana.
- Department of Medical Microbiology, School of Biomedical & Allied Health Sciences, University of Ghana, Accra, Ghana.
- Department of Pharmaceutics, School of Pharmacy, Central University, Miotso, Ghana.
ORCID-Profile: Ofosua Adi-Dako, Kwabena Ofori-Kwakye, Seth Kwabena Amponsah
Förderung
- Universities Science, Humanities and Engineering Partnerships in Africa
- University of Ghana
Zitieren
APA
Adi-Dako, O., Ofori-Kwakye, K., Amponsah, S. K., Boamah, I., Kuntworbe, N., & Oppong, E. E. (2018). Potential of Cocoa Pod Husk Pectin-Based Modified Release Capsules as a Carrier for Chronodelivery of Hydrocortisone in Sprague-Dawley Rats. Journal of Drug Delivery, 2018, 1-8. https://doi.org/10.1155/2018/9825363
Vancouver
Adi-Dako O, Ofori-Kwakye K, Amponsah SK, Boamah I, Kuntworbe N, Oppong EE. Potential of Cocoa Pod Husk Pectin-Based Modified Release Capsules as a Carrier for Chronodelivery of Hydrocortisone in Sprague-Dawley Rats. Journal of Drug Delivery. 2018;2018:1-8. doi:10.1155/2018/9825363
BibTeX
@article{AdiDako2018,
author = {Adi-Dako, Ofosua and Ofori-Kwakye, Kwabena and Amponsah, Seth Kwabena and Boamah, Isaac and Kuntworbe, Noble and Oppong, Esther Eshun},
title = {Potential of Cocoa Pod Husk Pectin-Based Modified Release Capsules as a Carrier for Chronodelivery of Hydrocortisone in Sprague-Dawley Rats},
journal = {Journal of Drug Delivery},
year = {2018},
volume = {2018},
pages = {1--8},
doi = {10.1155/2018/9825363}
}
EUVIMED